Tip Card: Sarclisa®

Sarclisa is a novel monoclonal antibody directed against the CD38 receptor on the surface of myeloma cells. This is described as a targeted anti-myeloma therapy. Sarclisa both kills myeloma cells directly and recruits surrounding immune cells to enhance the killing process.

*updated 7/27/2022

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.